Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065624 · ClinicalTrials.gov registry record · Phase 2
Antioxidant Functions of Lipoic Acid
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00065624 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 16 participants.
The verdict
NCT00065624, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether a short treatment with lipoic acid, an antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity and decreases oxidant stress in persons with elevated blood cholesterol.
Interventions
- DRUG lipoic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00065624
The ClinicalTrials.gov registry entry for NCT00065624 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lipoic acid is the first listed.
NCT00065624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00065624 about?
NCT00065624 is a clinical study titled "Antioxidant Functions of Lipoic Acid". The goal of this study is to determine whether a short treatment with lipoic acid, an antioxidant used in the treatment of diabetic neuropathy, improves blood vessel reactivity and decreases oxidant stress in persons with elevated blood cholesterol.
What is the current status of trial NCT00065624?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2003-11. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00065624?
The interventions under investigation include: lipoic acid (DRUG).
Who is sponsoring clinical trial NCT00065624?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.